Table 2.
Sub distribution Hazard model of waitlist mortality.
Hazard Ratio | 95% Cl | p-value | |
---|---|---|---|
Sensitization | |||
No UA-HLA Data Reported | Reference | Reference | Reference |
CPRA < 50 | 0.84 | 0.756 to 0.933 | 0.001 |
CPRA ≥ 50 | 1.71 | 1.553 to 1.883 | < 0.001 |
Gender | |||
Female | Reference | Reference | Reference |
Male | 0.709 | 0.663 to 0.758 | < 0.001 |
Age at Listing, by Year | 0.999 | 0.993 to 1.006 | 0.086 |
LAS at Listing | 1.02 | 1.015 to 1.026 | < 0.001 |
Primary Diagnosis | |||
Group A | Reference | Reference | Reference |
Group B | 2.151 | 1.861 to 2.487 | < 0.001 |
Group C | 1.197 | 1.041 to 1.375 | 0.011 |
Group D | 1.732 | 1.601 to 1.874 | < 0.001 |
ECMO at Registration | 1.094 | 0.869 to 1.377 | 0.45 |
Ventilator at Registration | 3.439 | 2.995 to 3.949 | < 0.001 |
Blood Type | |||
Type A | Reference | Reference | Reference |
Type AB | 0.994 | 0.832 to 1.187 | 0.94 |
Type B | 1.136 | 1.022 to 1.261 | 0.18 |
Type O | 1.122 | 1.048 to 1.202 | 0.001 |